Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Aether Holdings, Inc. announced the acquisition of a 60% interest in Noviant, a technology services company with expertise in enterprise infrastructure, cloud, cybersecurity, and managed IT services. This acquisition strengthens Aether Compute's AI infrastructure strategy by integrating Noviant's deployment, management, and support services, positi…
Blue Owl has been punished with headline risk and heavy short interest, but its underlying economics - $1.32B in free cash flow, a $19B market cap, and a dividend supported by recurring fee income - argue for a constructive trade. This is a tactical long: enter near current levels, protect with a defined stop, and target meaningful upside as flows …
XPO, Inc., a leading North American freight transportation company, has appointed Jonas Svedlund as its new Chief Legal Officer. Svedlund brings significant legal expertise from his previous roles at Thermo Fisher Scientific and General Electric, and will oversee legal, compliance, corporate governance, and commercial matters at XPO.
Assured Guaranty (AGO) has tumbled into oversold territory after a heavy session that left the shares near the 52-week low. Fundamentals remain intact: ~$3.3B market cap, P/E below 10, price-to-book around 0.6 and a modest quarterly dividend. This trade targets a mean-reversion recovery toward $85 while keeping a tight stop under recent support.
Standard Chartered has started coverage on Chainlink’s LINK token, assigning a $200 target for the end of 2030. The bank’s digital assets research head links the forecast to anticipated growth in tokenization and decentralized finance, and models steep increases in oracle and platform fee revenue that would support significant appreciation in LINK’…
Sandisk plunged after guiding conservatively and prioritizing long-term contracts worth roughly $93.9 billion. The market punished near-term growth misses; we see a tradeable long where consensus is overly focused on the cycle and is underweight the value of multi-year contracted revenue and strong cash generation. Entry at current levels, tight st…
Agnico Eagle combines scale, a steady dividend and a diversified asset base across high-quality deposits. At a market cap of ~$103.8B and a trailing PE of ~12.6, the stock looks fairly valued for a top-tier producer and still has room to run toward $220 with continued gold strength and steady operational execution. Technical momentum is bullish, bu…
Meta's free cash flow has softened relative to its size, leaving the stock stretched on a P/FCF basis. Still, the company is doubling down on AI and infrastructure with capex guidance that should boost ad targeting and monetization over the next 12-18 months. This trade idea buys that optionality at $604.01, uses a $540 stop, and targets $720 over …
Berkshire reported solid operating earnings growth, increased repurchases and continues to generate meaningful free cash flow. At roughly $1.12T market cap and a P/E near 15.5, the stock offers a conservative equity exposure with management buying back shares aggressively. I lay out a mid-term trade with explicit entry, stop and target, plus the ke…
Autozi Internet Technology's Hong Kong subsidiary intends to acquire significant economic exposure to SpaceX through a fund or similar vehicle as a strategic treasury asset. The transaction is pending due diligence, financing, and approvals. Autozi aims to enhance shareholder value by diversifying into innovative global technology assets like Space…
Oruka Therapeutics announced solid second quarter financial results with a strong cash position of $1.1 billion, enabling funding through a Biologics License Application (BLA) filing for ORKA-001. The company advanced key clinical programs including positive Phase 2a data for ORKA-001 in plaque psoriasis, full enrollment in EVERLAST-B Phase 2b tria…
Bitdeer Technologies Group disclosed its unaudited financial results for Q2 2026 with total revenue increasing substantially to $228.8 million driven by major growth in self-mining and AI cloud segments. Despite higher revenues, the company experienced a gross loss of $8.5 million and a net loss of $92.3 million, impacted by rising electricity cost…
Kaspi.kz announced robust 2Q and 1H 2026 financial results with strong growth in e-Commerce, Payments, and Fintech segments. The company launched Kasper, a personal AI shopping assistant, seeing rapid user adoption, and declared an 18% increase in quarterly dividends. Kaspi.kz also completed the acquisition of Rabobank A.Ş. in Türkiye to expand its…
Tenax Therapeutics announced topline results from its Phase 3 LEVEL trial evaluating oral levosimendan (TNX-103) in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The study did not meet its primary endpoint of improvement in 6-minute walk distance or the key secondary endpoint of symp…
Grifols announced the completion of the clinical portion of its SPARTA Phase 3 trial evaluating two dosage regimens of Prolastin®-C in patients with emphysema caused by alpha-1 antitrypsin deficiency (AATD). The trial enrolled 345 patients across 16 countries and utilized lung CT densitometry as the primary endpoint. The results are expected by the…
Shopify posted 34% revenue growth and a tripling of AI-driven orders in Q2, reaffirming its role as the infrastructure layer for modern commerce. The platform's GMV scale, recurring merchant revenue, and expanding services mix justify paying up, but the stock trades at premium multiples. This trade targets a breakout above the 52-week high with a d…
Tonix Pharmaceuticals Holding Corp. reported a significant 197% increase in net sales of TONMYA in Q2 2026, reaching approximately $11 million. Coverage now includes about 136 million U.S. lives, with further expansion expected in managed Medicare starting January 2027. The company initiated a Phase 2 study for TNX-102 SL in major depressive disord…
Jade Biosciences announced encouraging second quarter 2026 financial results and significant clinical updates including positive interim Phase 1 data for JADE101 in IgA nephropathy, initiation of Phase 2 and planned Phase 3 trials, and progress with JADE201 and JADE301 programs targeting autoimmune diseases. The company reported a robust cash posit…
Ceribell, Inc., a medical technology firm specializing in neurological diagnostics, announced FDA 510(k) clearance for two new AI-driven features—Epileptiform Abnormality Detection and Artifact Reduction—integrated into its cloud-based Neurology Portal. These enhancements improve the accuracy and efficiency of EEG evaluations in critical care setti…
Bernstein lowered its adjusted EPS forecasts for Novo Nordisk across the 2026-2031 period, projecting results as much as 15% below Bloomberg consensus, mainly due to anticipated U.S. share erosion to Eli Lilly in injectable GLP-1 obesity and diabetes therapies. The broker kept an underperform rating while raising its price target modestly, citing l…
A surprising drop in July payrolls failed to trigger a decisive move in interest rate markets, where investors still place roughly even odds on a Federal Reserve rate increase next month. That restraint reflected a mix of factors including a fall in the unemployment rate, higher oil prices, fresh political pressure on a Fed governor, heavy Treasury…
Veru Inc. reported its fiscal third quarter 2026 financial results, highlighting full enrollment of 239 patients in its Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide for high quality weight loss in older obese patients. The company entered a clinical supply agreement with Novo Nordisk and received a USPTO noti…
Aeries Technology, Inc. reported strong first-quarter fiscal 2027 results with a 43% year-over-year revenue increase to $21.9 million, significant improvements in profitability, and operating cash flow of $4.8 million. The company reaffirmed its fiscal year 2027 guidance and launched AxAI, an agentic AI solution, expanding its AI transformation str…
Ryman Hospitality Properties, Inc. announced a definitive agreement to acquire Grande Lakes Orlando Resort for $1.38 billion. The purchase includes two luxury hotels and an 18-hole golf course, operated by Marriott International. This acquisition aligns with the company's strategy to expand its upscale convention center resorts and is expected to b…
Schneider’s diversified transport mix, recent accretive M&A and a low leverage profile make it a compelling swing trade as industry pricing and volumes recover. Entry at $36.00, stop $33.00, target $41.50 over a 45 trading day horizon.
